Veterinary Medicines

Cevac MD HVT suspension and solvent for suspension for injection for chickens

Authorised
  • Turkey herpesvirus, strain FC126, Live
Download as PDF

Product identification

Medicine name:
Cevac MD HVT suspension and solvent for suspension for injection for chickens
Cevac MD HVT, Koncentrát a rozpouštědlo pro injekční suspenzi
Active substance:
  • Turkey herpesvirus, strain FC126, Live
Target species:
  • Chicken (embryonated eggs)
  • Chicken
Route of administration:
  • In ovo
  • Subcutaneous use

Product details

Active substance and strength:
  • Turkey herpesvirus, strain FC126, Live
    8000.00
    plaque forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension and solvent for suspension for injection
Withdrawal period by route of administration:
  • In ovo
    • Chicken (embryonated eggs)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Package description:
  • bag containing 1600 ml
  • bag containing 1200 ml
  • bag containing 1000 ml
  • bag containing 800 ml
  • bag containing 400 ml
  • bag containing 200 ml
  • 1 ampoule containing 4000 doses
  • 1 ampoule containing 2000 doses
  • 1 ampoule containing 1000 doses
  • 1 ampoule containing 500 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva-Phylaxia Zrt.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
  • 97/103/16-C
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0264/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download
Czech (PDF)
Published on: 25/10/2022
Download

Package Leaflet

English (PDF)
Published on: 22/12/2023
Download
Czech (PDF)
Published on: 25/10/2022
Download

Labelling

English (PDF)
Published on: 22/12/2023
Download
Czech (PDF)
Published on: 25/10/2022
Download

eu-PUAR-esv0264001-dcp-cevac-md-hvt-suspension-and-solvent-for-suspension-for-injection-en.pdf

English (PDF)
Published on: 22/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."